Literature DB >> 10706695

Vigorous allograft rejection in the absence of danger.

A W Bingaman1, J Ha, S Y Waitze, M M Durham, H R Cho, C Tucker-Burden, R Hendrix, S R Cowan, T C Pearson, C P Larsen.   

Abstract

Tolerance to self is a necessary attribute of the immune system. It is thought that most autoreactive T cells are deleted in the thymus during the process of negative selection. However, peripheral tolerance mechanisms also exist to prevent development of autoimmune diseases against peripheral self-Ags. It has been proposed that T cells develop tolerance to peripheral self-Ags encountered in the absence of inflammation or "danger" signals. We have used immunodeficient Rag 1-/- mice to study the response of T cells to neo-self peripheral Ags in the form of well-healed skin and vascularized cardiac allografts. In this paper we report that skin and cardiac allografts without evidence of inflammation are vigorously rejected by transferred T cells or when recipients are reconstituted with T cells at a physiologic rate by nude bone graft transplantation. These results provide new insights into the role of inflammation or "danger" in the initiation of T cell-dependent immune responses. These findings also have profound implications in organ transplantation and suggest that in the absence of central deletional tolerance, peripheral tolerance mechanisms are not sufficient to inhibit alloimmune responses even in the absence of inflammation or danger.

Entities:  

Mesh:

Year:  2000        PMID: 10706695     DOI: 10.4049/jimmunol.164.6.3065

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Skin allograft maintenance in a new synchimeric model system of tolerance.

Authors:  N N Iwakoshi; T G Markees; N Turgeon; T Thornley; A Cuthbert; J Leif; N E Phillips; J P Mordes; D L Greiner; A A Rossini
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

2.  Intravital microscopy identifies selectins that regulate T cell traffic into allografts.

Authors:  Thomas R Jones; Nozomu Shirasugi; Andrew B Adams; Thomas C Pearson; Christian P Larsen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 3.  Transplant tolerance: models, concepts and facts.

Authors:  Nicola J Monk; Roseanna E G Hargreaves; Elizabeth Simpson; Julian P Dyson; Stipo Jurcevic
Journal:  J Mol Med (Berl)       Date:  2006-02-25       Impact factor: 4.599

Review 4.  The innate immune system in allograft rejection and tolerance.

Authors:  David F LaRosa; Adeeb H Rahman; Laurence A Turka
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

5.  Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154.

Authors:  He Xu; Xiaojie Zhang; Roslyn B Mannon; Allan D Kirk
Journal:  J Clin Invest       Date:  2006-02-23       Impact factor: 14.808

6.  A discussion of immune tolerance and the layered immune system hypothesis.

Authors:  Jeff E Mold; Colin C Anderson
Journal:  Chimerism       Date:  2013-05-03

7.  Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts.

Authors:  Franco B Mueller; Hua Yang; Michelle Lubetzky; Akanksha Verma; John R Lee; Darshana M Dadhania; Jenny Z Xiang; Steven P Salvatore; Surya V Seshan; Vijay K Sharma; Olivier Elemento; Manikkam Suthanthiran; Thangamani Muthukumar
Journal:  JCI Insight       Date:  2019-07-11

Review 8.  The innate immune system in transplantation.

Authors:  Martin H Oberbarnscheidt; Daniel Zecher; Fadi G Lakkis
Journal:  Semin Immunol       Date:  2011-07-01       Impact factor: 11.130

9.  Non-self recognition by monocytes initiates allograft rejection.

Authors:  Martin H Oberbarnscheidt; Qiang Zeng; Qi Li; Hehua Dai; Amanda L Williams; Warren D Shlomchik; David M Rothstein; Fadi G Lakkis
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

Review 10.  Innate allorecognition by monocytic cells and its role in graft rejection.

Authors:  F G Lakkis; X C Li
Journal:  Am J Transplant       Date:  2017-08-24       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.